Like p16INK4, loss of RB1 function by genetic deletion is commonly seen to be an essential process of oncogenesis in wide ranges of human malignancy, such as retinoblastoma, breast cancer, and small cell carcinoma of the lungs. This evidence concerns the gene CDKN2A and small cell lung carcinoma.